FULC vs GLD
Fulcrum Therapeutics Inc (FULC) versus SPDR® Gold Shares (GLD) — a side-by-side from cached financials, not a winner call.
Fulcrum Therapeutics Inc (FULC) is a biotechnology company listed on US.
SPDR® Gold Shares (GLD) common stock listed on NYSE ARCA.
Latest reported FULC revenue for 2025-09-30 was $0. Net income was -$54.5M. FULC currently screens at market cap $427.0M.
GLD does not have a complete income-statement cache yet.
FULC currently screens at market cap $427.0M. GLD currently screens at market cap $0.
Not investment advice. Open the FULC and GLD stock pages for the full models.
Not investment advice.